Maharashtra Woman Dies Of Rabies 3 Days After Completing Vaccine Course

Kolhapur: A 21-year-old woman from Maharashtra’s Kolhapur died of rabies three days after she completed the anti-rabies vaccination course.

The woman, Srishti Shinde, was bitten by a stray dog on February 3 on Bhausingji Road. She was on her way to Shaniwar Peth and had stopped on the road to answer a phone call when a stray dog bit her on her leg.

However, days later, she developed a fever and lost strength in both her legs.

Srishti Shinde was admitted to a private hospital where several tests were conducted and was put on a ventilator after her condition worsened. The test reports revealed that she was infected with rabies.

Shinde was later taken to a government hospital for further treatment, but she died the next day.

Srishti Shinde’s death has raised questions about how she contracted rabies despite completing the vaccine course. Her family is asking whether the vaccine was not kept at the required temperature.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre